Format

Send to

Choose Destination
Trends Pharmacol Sci. 2006 Jan;27(1):1-4. Epub 2005 Nov 28.

In silico patent searching reveals a new cannabinoid receptor.

Author information

1
Department of Neuroinflammation, Institute of Neurology, University College London, 1 Wakefield Street, London WC1N 1PJ, UK. d.baker@ion.ucl.ac.uk

Abstract

Increasing evidence suggests that some cannabinoids mediate their effects independently of the known cannabinoid CB(1) and CB(2) receptors. Two recently published patents indicate that several cannabinoid receptor ligands also bind to the orphan G-protein-coupled receptor GPR55. This receptor is reported to be expressed in several tissues and might function in lipid or vascular biology. Thus, GPR55 might represent a new cannabinoid receptor.

PMID:
16318877
DOI:
10.1016/j.tips.2005.11.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center